Apollo Endosurgery, Inc. (APEN)

6.19 -0.09 (-1.43%) At close: 04:00PM EDT

Apollo Endosurgery, Inc.

Building 1
Suite 300 1120 South Capital of Texas Highway
Austin, TX 78746
United States
512 279 5100
https://www.apolloendo.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 202

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Charles S. McKhann	CEO, Pres & Director	963.53k	N/A	1969
Mr. Jeffrey G. Black	CFO, Sec. & Treasurer	524.02k	N/A	1969
Mr. John J. Molesphini	Exec. VP of Operations	502.58k	N/A	1958
Dr. Sergey Kantsevoy M.D.	Co-Founder and Innovation Partner	N/A	N/A	N/A
Mr. Anthony Kalloo M.D.	Co-Founder and Innovation Partner	N/A	N/A	N/A
Dr. Robert Hawes M.D.	Co-Founder and Innovation Partner	N/A	N/A	N/A
Dr. Peter Benjamin Cotton M.D.	Co-Founder and Innovation Partner	N/A	N/A	N/A
Dr. Christopher J. Gostout M.D.	Co-Founder & Chief Medical Officer	N/A	N/A	1951
Mr. Sydney Chung M.D.	Co-Founder and Innovation Partner	N/A	N/A	N/A
Dr. Pankaj Jay Pasricha FACP, M.D., MBBS	Co-Founder	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Corporate Governance

Apollo Endosurgery, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.